GE-145 320 mg/mL Injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GE-145 320 mg/mL Injection, covering 2014-05-02 to 2014-05-02. Get the full timeline:
Most recent: Clinical Trial Update: Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary Procedure [Phase 2]